Cardinal Health (FRA:CLH) Piotroski F-Score: 7 (As of Jun. 25, 2026) — 17% Above Median


FRA:CLH Cardinal Health Inc FRA:CLH
81 GF Score
Price €200.70
GF Value €119.69
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cardinal Health Piotroski F-Score?

Cardinal Health FRA:CLH +3.86% 81 Piotroski F-Score is 7 as of Jun. 25, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates FRA:CLH with a GF Score™ of 81/100 and a GF Value™ of €119.69 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 114 Medical Distribution companies, Cardinal Health ranks better than 89.47% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cardinal Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Cardinal Health's Piotroski F-Score or its related term are showing as below:

FRA:CLH' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of Cardinal Health was 8. The lowest was 4. And the median was 6.

Cardinal Health  (FRA:CLH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Cardinal Health Piotroski F-Score Related Terms


Cardinal Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Cardinal Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardinal Health Piotroski F-Score Chart

Cardinal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 7.00 6.00 6.00

Cardinal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 8.00 7.00 7.00

FRA:CLH vs COR, HSIC, MCK: Piotroski F-Score Comparison

For the Medical Distribution subindustry, Cardinal Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardinal Health Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cardinal Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Cardinal Health's Piotroski F-Score falls into.


FRA:CLH
81GF Score
Cardinal Health Inc FRA:CLH
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 207.213 + 383.4 + 398.818 + 345.135 = €1,335 Mil.
Cash Flow from Operations was 1317.84 + 828.996 + 585.844 + 1576.895 = €4,310 Mil.
Revenue was 52157.853 + 54535.668 + 56045.458 + 52713.1 = €215,452 Mil.
Gross Profit was 1909.134 + 1975.788 + 2047.038 + 2160.77 = €8,093 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(46130.675 + 46056.774 + 47054.256 + 49602.882 + 49035.985) / 5 = €47576.1144 Mil.
Total Assets at the begining of this year (Mar25) was €46,131 Mil.
Long-Term Debt & Capital Lease Obligation was €7,132 Mil.
Total Current Assets was €32,925 Mil.
Total Current Liabilities was €36,320 Mil.
Net Income was 218.315 + 374.816 + 382 + 468.05 = €1,443 Mil.

Revenue was 55616.443 + 47101.577 + 52777.12 + 50762.15 = €206,257 Mil.
Gross Profit was 1748.378 + 1713.702 + 1853.655 + 1963.775 = €7,280 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(42209.6 + 41917.409 + 38796.159 + 44886.91 + 46130.675) / 5 = €42788.1506 Mil.
Total Assets at the begining of last year (Mar24) was €42,210 Mil.
Long-Term Debt & Capital Lease Obligation was €6,601 Mil.
Total Current Assets was €32,000 Mil.
Total Current Liabilities was €33,912 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cardinal Health's current Net Income (TTM) was 1,335. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cardinal Health's current Cash Flow from Operations (TTM) was 4,310. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1334.566/46130.675
=0.02893012

ROA (Last Year)=Net Income/Total Assets (Mar24)
=1443.181/42209.6
=0.03419082

Cardinal Health's return on assets of this year was 0.02893012. Cardinal Health's return on assets of last year was 0.03419082. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Cardinal Health's current Net Income (TTM) was 1,335. Cardinal Health's current Cash Flow from Operations (TTM) was 4,310. ==> 4,310 > 1,335 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=7131.925/47576.1144
=0.14990558

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=6600.8/42788.1506
=0.15426701

Cardinal Health's gearing of this year was 0.14990558. Cardinal Health's gearing of last year was 0.15426701. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=32925.36/36320.485
=0.90652314

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=32000.375/33912.35
=0.9436201

Cardinal Health's current ratio of this year was 0.90652314. Cardinal Health's current ratio of last year was 0.9436201. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Cardinal Health's number of shares in issue this year was 236. Cardinal Health's number of shares in issue last year was 241. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=8092.73/215452.079
=0.03756162

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=7279.51/206257.29
=0.03529335

Cardinal Health's gross margin of this year was 0.03756162. Cardinal Health's gross margin of last year was 0.03529335. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=215452.079/46130.675
=4.67047315

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=206257.29/42209.6
=4.88650189

Cardinal Health's asset turnover of this year was 4.67047315. Cardinal Health's asset turnover of last year was 4.88650189. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cardinal Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Cardinal Health (FRA:CLH) has a Piotroski F-Score of 7 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Cardinal Health and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Cardinal Health's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Cardinal Health ranks #12 out of 114 companies in the Medical Distribution industry, placing it in the top 10.5%.
Is Cardinal Health's Piotroski F-Score too high?
Cardinal Health's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Cardinal Health's value of 7 is 40% above this industry median. Based on the distribution chart, Cardinal Health ranks #12 out of 114 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Piotroski F-Score compare to COR and HSIC?
According to the Medical Distribution industry distribution chart, Cardinal Health ranks #12 out of 114 companies for Piotroski F-Score. This places Cardinal Health in the top 11% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Cardinal Health's value of 7 is 40% above this benchmark. Historically, Cardinal Health's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Cardinal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 114 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardinal Health's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Cardinal Health and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardinal Health's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (FRA:CLH) is currently considered Significantly Overvalued. The stock's GF Value™ is €119.69, compared to a current price of €200.70 — trading 67.7% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Medical Distribution industry median of 5.00. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Cardinal Health (FRA:CLH), the current Piotroski F-Score is 7 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardinal Health (FRA:CLH) Overvalued in 2026?

Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued. The current stock price of €200.70 is trading 67.7% above its estimated GF Value™ of €119.69. GuruFocus considers Cardinal Health to be Significantly Overvalued.

Key valuation signals for FRA:CLH:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: €119.69 vs. price of €200.70 (67.7% above fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 40% above the Medical Distribution median (#12 of 114)

No single metric tells the full story. See the FRA:CLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cardinal Health Business Description

Address 7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score

Get the complete analysis for FRA:CLH

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€200.70
Price
€119.69
GF Value